![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mrpl50 | Mouse | (+)-dexrazoxane | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of MRPL50 mRNA | CTD | PMID:26873546 | Mrpl50 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL50 mRNA | CTD | PMID:36331819 | Mrpl50 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL50 mRNA | CTD | PMID:22206623 | Mrpl50 | Mouse | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of MRPL50 mRNA | CTD | PMID:22206623 | Mrpl50 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MRPL50 promoter] | CTD | PMID:19654925 | Mrpl50 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL50 mRNA | CTD | PMID:20106945 and PMID:21632981 | Mrpl50 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL50 mRNA | CTD | PMID:21570461 | Mrpl50 | Mouse | 4,4'-sulfonyldiphenol | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of MRPL50 gene | CTD | PMID:31601247 | Mrpl50 | Mouse | aflatoxin B1 | increases methylation | ISO | MRPL50 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MRPL50 gene | CTD | PMID:27153756 | Mrpl50 | Mouse | all-trans-retinoic acid | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MRPL50 mRNA | CTD | PMID:21934132 and PMID:33167477 | Mrpl50 | Mouse | alpha-Zearalanol | multiple interactions | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MRPL50 mRNA | CTD | PMID:35163327 | Mrpl50 | Mouse | amitrole | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of MRPL50 mRNA | CTD | PMID:30047161 | Mrpl50 | Mouse | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of MRPL50 mRNA | CTD | PMID:23650126 | Mrpl50 | Mouse | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of MRPL50 protein | CTD | PMID:37955338 | Mrpl50 | Mouse | arsenite(3-) | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to MRPL50 mRNA] | CTD | PMID:32406909 | Mrpl50 | Mouse | benzo[a]pyrene | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MRPL50 mRNA | CTD | PMID:26238291 | Mrpl50 | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | Mrpl50 | Mouse | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of MRPL50 mRNA | CTD | PMID:28085963 | Mrpl50 | Mouse | bisphenol A | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MRPL50 mRNA | CTD | PMID:25181051 | Mrpl50 | Mouse | bisphenol A | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MRPL50 mRNA | CTD | PMID:29275510 | Mrpl50 | Mouse | bisphenol A | increases methylation | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of MRPL50 gene | CTD | PMID:28505145 | Mrpl50 | Mouse | cadmium dichloride | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of MRPL50 mRNA | CTD | PMID:26472689 | Mrpl50 | Mouse | cadmium dichloride | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of MRPL50 mRNA | CTD | PMID:38568856 | Mrpl50 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Mrpl50 | Mouse | chloropicrin | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of MRPL50 mRNA | CTD | PMID:28476498 | Mrpl50 | Mouse | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of MRPL50 mRNA | CTD | PMID:28472532 | Mrpl50 | Mouse | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of MRPL50 mRNA | CTD | PMID:18353800 | Mrpl50 | Mouse | cyclosporin A | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MRPL50 mRNA | CTD | PMID:25562108 | Mrpl50 | Mouse | cylindrospermopsin | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of MRPL50 mRNA | CTD | PMID:24921660 | Mrpl50 | Mouse | Dibutyl phosphate | affects expression | ISO | MRPL50 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of MRPL50 mRNA | CTD | PMID:37042841 | Mrpl50 | Mouse | dicrotophos | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of MRPL50 mRNA | CTD | PMID:28302478 | Mrpl50 | Mouse | dorsomorphin | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Mrpl50 | Mouse | doxorubicin | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of MRPL50 mRNA | CTD | PMID:26873546 | Mrpl50 | Mouse | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MRPL50 mRNA | CTD | PMID:26873546 | Mrpl50 | Mouse | enzyme inhibitor | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MRPL50 protein | CTD | PMID:23301498 | Mrpl50 | Mouse | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of MRPL50 mRNA | CTD | PMID:30319688 | Mrpl50 | Mouse | ethyl methanesulfonate | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of MRPL50 mRNA | CTD | PMID:23649840 | Mrpl50 | Mouse | fenthion | decreases expression | EXP | | 6480464 | Fenthion results in decreased expression of MRPL50 mRNA | CTD | PMID:34813904 | Mrpl50 | Mouse | finasteride | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of MRPL50 mRNA | CTD | PMID:24136188 | Mrpl50 | Mouse | flutamide | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of MRPL50 mRNA | CTD | PMID:24136188 | Mrpl50 | Mouse | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of MRPL50 mRNA | CTD | PMID:25629700 | Mrpl50 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL50 mRNA | CTD | PMID:22206623 | Mrpl50 | Mouse | fulvestrant | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of MRPL50 gene | CTD | PMID:31601247 | Mrpl50 | Mouse | ivermectin | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MRPL50 protein | CTD | PMID:32959892 | Mrpl50 | Mouse | ketamine | decreases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of MRPL50 mRNA | CTD | PMID:20080153 | Mrpl50 | Mouse | leflunomide | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | leflunomide results in increased expression of MRPL50 mRNA | CTD | PMID:24136188 | Mrpl50 | Mouse | lipopolysaccharide | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of MRPL50 mRNA | CTD | PMID:31059760 | Mrpl50 | Mouse | methimazole | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of MRPL50 mRNA | CTD | PMID:30047161 | Mrpl50 | Mouse | methyl methanesulfonate | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of MRPL50 mRNA | CTD | PMID:23649840 | Mrpl50 | Mouse | nefazodone | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of MRPL50 mRNA | CTD | PMID:24136188 | Mrpl50 | Mouse | nickel atom | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Nickel results in increased expression of MRPL50 mRNA | CTD | PMID:25583101 | Mrpl50 | Mouse | nimesulide | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of MRPL50 mRNA | CTD | PMID:24136188 | Mrpl50 | Mouse | oxaliplatin | multiple interactions | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MRPL50 mRNA | CTD | PMID:25729387 | Mrpl50 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MRPL50 mRNA | CTD | PMID:17562736 | Mrpl50 | Mouse | paracetamol | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of MRPL50 mRNA | CTD | PMID:31059760 | Mrpl50 | Mouse | paracetamol | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MRPL50 mRNA | CTD | PMID:25704631 | Mrpl50 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL50 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL50 mRNA | CTD | PMID:36331819 | Mrpl50 | Mouse | perfluorooctanoic acid | multiple interactions | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MRPL50 mRNA | CTD | PMID:35163327 | Mrpl50 | Mouse | phenobarbital | affects expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of MRPL50 mRNA | CTD | PMID:19159669 | Mrpl50 | Mouse | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of MRPL50 mRNA | CTD | PMID:18445702 | Mrpl50 | Mouse | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MRPL50 mRNA | CTD | PMID:21278054 | Mrpl50 | Mouse | quercetin | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of MRPL50 mRNA | CTD | PMID:21632981 | Mrpl50 | Mouse | resorcinol | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | resorcinol results in increased expression of MRPL50 mRNA | CTD | PMID:22623647 | Mrpl50 | Mouse | SB 431542 | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Mrpl50 | Mouse | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of MRPL50 mRNA | CTD | PMID:19073995 | Mrpl50 | Mouse | sodium arsenite | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MRPL50 mRNA | CTD | PMID:38568856 | Mrpl50 | Mouse | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPL50 mRNA | CTD | PMID:21641980 | Mrpl50 | Mouse | sulfadimethoxine | increases expression | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of MRPL50 mRNA | CTD | PMID:30047161 | Mrpl50 | Mouse | sunitinib | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of MRPL50 mRNA | CTD | PMID:31533062 | Mrpl50 | Mouse | thimerosal | increases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of MRPL50 mRNA | CTD | PMID:27188386 | Mrpl50 | Mouse | thiram | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Thiram results in decreased expression of MRPL50 mRNA | CTD | PMID:38568856 | Mrpl50 | Mouse | topotecan | multiple interactions | ISO | Mrpl50 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MRPL50 mRNA | CTD | PMID:25729387 | Mrpl50 | Mouse | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of MRPL50 mRNA | CTD | PMID:19448997 | Mrpl50 | Mouse | trichostatin A | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of MRPL50 mRNA | CTD | PMID:26272509 | Mrpl50 | Mouse | trichostatin A | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRPL50 mRNA | CTD | PMID:27188386 | Mrpl50 | Mouse | triphenyl phosphate | affects expression | ISO | MRPL50 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MRPL50 mRNA | CTD | PMID:37042841 | Mrpl50 | Mouse | urethane | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Urethane results in decreased expression of MRPL50 mRNA | CTD | PMID:28818685 | Mrpl50 | Mouse | valproic acid | decreases methylation | ISO | MRPL50 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MRPL50 gene | CTD | PMID:29154799 | Mrpl50 | Mouse | valproic acid | multiple interactions | ISO | MRPL50 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRPL50 mRNA | CTD | PMID:27188386 | Mrpl50 | Mouse | valproic acid | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MRPL50 mRNA | CTD | PMID:23179753 and PMID:26272509 | Mrpl50 | Mouse | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MRPL50 mRNA | CTD | PMID:17292431 | Mrpl50 | Mouse | vincristine | decreases expression | ISO | MRPL50 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of MRPL50 mRNA | CTD | PMID:23649840 | |